Abstract
Cancer is one of the main causes of mortality in the world and its early detection significantly increases chances of patients’ survival. High cancer mortality rate is caused mainly by late-stage diagnosis and lack of non-invasive and reliable methods for early diagnosis, such as plasma biomarkers. The incidence of cancers in the world still grows so it is crucial to develop a new, faster, high specificity and more sensitive diagnostic technologies. Several recent researchers indicate amino acids as a potential marker for cancer detection. An ideal cancer biomarker should be characterized by high specificity and sensitivity, reliability, ease of measurement and, what is important, ability to detect disease in its early stage. This study is focused on indicating metabolic amino acid profiling as a method of identifying biomarkers for cancer early detection and screening. Presented results are derived from the most recent studies where patients in early, often asymptomatic stages of disease constituted a large percentage of all the patients and, what is important, where researchers have observed alterations in these patients’ amino acid profiles. This review is concentrated on analyzing studies on the most common cancers with high mortality rate. Inventing effective methods of early diagnosis is particularly important in case of such diseases. Research presented in this publication is focused on patients with lung, breast and colon cancer. In all analyzed cases, significant changes in the amino acid profile in cancer patients comparing to healthy controls were observed. This study indicates potential of amino acid profiling as method for early cancer detection.
Similar content being viewed by others
References
Abdulrahman GO Jr, Rahman GA (2012) Epidemiology of breast cancer in Europe and Africa. J Cancer Epidemiol 2012:1–5. doi:10.1155/2012/915610
Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:29–55
Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14:754–762. doi:10.1038/nrc3829
Armitage EG, Barbas C (2014) Metabolomics in cancer biomarker discovery: current trends and future perspectives. J Pharm Biomed 87:1–11. doi:10.1016/j.jpba.2013.08.041
Asiago VM, Alvarado LZ, Shanaiah N, Gowda GA, Owusu-Sarfo K, Ballas RA, Raftery D (2010) Early detection of recurrent breast cancer using metabolite profiling. Cancer Res 70(21):8309–8318. doi:10.1158/0008-5472
Barnes T, Bell K, DiSebastiano KM, Vance V, Hanning R, Russell C, Dubin JA, Bahl M, Califaretti N, Campbell C, Mourtzakis M (2014) Plasma amino acid profiles of breast cancer patients early in the trajectory of the disease differ from healthy comparison groups. Appl Physiol Nutr Metab 39(6):740–744. doi:10.1139/apnm-2013-0526
Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P (2008) Smoking and colorectal cancer: a meta-analisys. JAMA 300(23):2765–2778. doi:10.1001/jama.2008.839
Bretthauer M (2010) Evidence for colorectal cancer screening. Best Pract Res Clin Gastroenterol 24:417–425
Budczies J, Denkert C, Muller BM, Brockmoller SF, Klauschen F, Gyorffy B, Dietel M, Richter-Ehrenstein C, Marten U, Salek RM, Griffin JL, Hilvo M, Oresic M, Wohlgemuth G, Fiehn O (2012) Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue—a GC-TOFMS based metabolomics study. BMC Genom 13(334):1–11. doi:10.1186/1471-2164-13-334
Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378. doi:10.3322/caac.20038
Delgado-Povedano MM, Calderón-Santiag M, Priego-Capote F, Luque de Castro MD (2015) Study of sample preparation for quantitative analysis of amino acids in human sweat by liquid chromatography–tandem mass spectrometry. Talanta 146:310–317. doi:10.1016/j.talanta.2015.07.066
Denkert C, Bucher E, Hilvo M, Salek R, Oresic M, Griffin J, Brockmöller S, Klauschen F, Loibl S, Barupal DK, Budczies J, Iljin K, Nekljudova V, Fiehn O (2012) Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery. Genome Med 4(4):37
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917. doi:10.1002/ijc.25516
Fukutake N, Ueno M, Hiraoka N, Shimada K, Shiraishi K, Saruki N, Ito T, Yamakado M, Ono N, Imaizumi A, Kikuchi S, Yamamoto H, Katayama K (2015) A novel multivariate index for pancreatic cancer detection based on the plasma free amino acid profile. PLoS One 10(7):1–15. doi:10.1371/journal.pone.0132223
Gao Y, Gao F, Ma JI, Zhang XZ, Li Y, Song LP, Zhao DI (2015) Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients. Patient Prefer Adherence 9:1189–1194. doi:10.2147/PPA.S87069
Gu Y, Chen T, Fu S, Sun X, Wang L, Lu Y, Ding S, Ruan G, Teng L, Wang M (2015) Perioperative dynamics and significance of amino acid profiles in patients with cancer. J Transl Med 13(35):1–14. doi:10.1186/s12967-015-0408-1
Hadi NI, Jamal Q (2015) “OMIC” tumor markers for breast cancer: a review. Park J Med Sci 31(5):1256–1262
Hasim A, Ali M, Mamtimin B, Ma JQ, Li QZ, Abudula A (2012) Metabonomic signature analysis of cervical carcinoma and pre-cancerous diseases in Uighur women by 1H-NMR spectroscopy. Exp Ther Med 3:945–951. doi:10.3892/etm.2012.509
Hasim A, Aili A, Maimaiti A, Mamtimin B, Abudula A, Upur H (2013) Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection. Mol Biol Rep 40(10):5853–5859. doi:10.1007/s11033-013-2691-3
Iachina M, Green A, Jakobsen E (2014) The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open 4:e003846. doi:10.1136/bmjopen-2013-003846
Kim JW, Lee G, Moon SM, Park MJ, Hong SK, Ahn JH, Kim KR, Paik MJ (2010) Metabolomic screening and star pattern recognition by urinary amino acid profile analysis from bladder cancer patient. Metabolomics 6:202–206. doi:10.1007/s11306-010-0199-6
Kim HJ, Jang SH, Ryu JS, Lee JE, Kim YC, Lee MK, Jang TW, Lee SY, Nakamura H, Nishikata N, Mori M, Noguchi Y, Miyano H, Lee KY (2015) The performance of a novel amino acid multivariate index for detecting lung cancer: a case control study in Korea. Lung Cancer 4958:1–6. doi:10.1016/j.lungcan.2015.10.006
Lai HS, Lee JC, Lee PH, Wang ST, Chen WJ (2005) Plasma free amino acid profile in cancer patients. Semin Cancer Biol 15(4):267–276
Laviano A, Cascino A, Muscaritoli M, Fanfarillo F, Rossi Fanelli F (2003) Tumor-induced changes in host metabolism: a possible role for free tryptophan as a marker of neoplastic disease. Adv Exp Med Biol 527:363–366
Lee JC, Chen MJ, Chang CH, Tiai YF, Lin PW, Lai HS, Wang ST (2003) Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma. Hepatogastroenterology 50(53):1269–1273
Leichtle AB, Nuoffer JM, Ceglarek U, Kase J, Conrad T, Witzigmann H, Thiery J, Fieldler GM (2012) Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics 8(4):634–653. doi:10.1007/s11306-011-0357-5
Lenz EM, Wilson ID (2007) Analytical strategies in metabonomics. J Proteome Res 6(2):443–458
Ma YL, Liu WJ, Peng JY, Zhang P, Chen HQ, Qin HL (2009) Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography–mass spectrometry. Chin J Gastrointest Surg 12(4):386–390
Madsen R, Lundstedt T, Trygg J (2010) Chemometrics in metabolomics—a review in human disease diagnosis. Anal Chim Acta 659:23–33. doi:10.1016/j.aca.2009.11.042
Maeda J, Higashiyama M, Imaizumi A, Nakayama T, Yamamoto H, Daimon T, Yamakado M, Imamura F, Kodama K (2010) Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study. BMC Cancer 10(690):1–8. doi:10.1186/1471-2407-10-690
Malati Y (2007) Tumor markers: an overview. Indian J Clin Biochem 22(2):17–31. doi:10.1007/BF02913308
Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Takeshi M, Saruki N, Bando E, Kimura H, Imamura F, Moriyama M, Ikeda I, Chiba A, Oshita F, Imaizumi A, Yamamoto H, Miyano H, Horimoto K, Tochikubo O, Mitsushima T, Yamakado M, Okamoto N (2011) Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One 6(9):e24143. doi:10.1371/journal.pone.0024143
Mustafa A, Gupta S, Hudes GR, Egleston BL, Uzzo RG, Kruger WD (2011) Serum amino acid levels as a biomarker for renal cell carcinoma. J Urol 186(4):1206–1212. doi:10.1016/j.juro.2011.05.085
Okamoto N (2012) Use of “AminoIndex Technology” for cancer screening. Ningen Dock 26:911–922
Okamoto N, Miyagi Y, Chiba A, Akaike M, Shiozawa M, Imaizumi A, Yamamoto H, Ando T, Yamakodo M, Tochikubo O (2009) Diagnostic modeling with differences in plasma amino acid profiles between non-cachectic colorectal/breast cancer patients and healthy individuals. Int J Med Med Sci 1:1–8
Poschke I, Mao Y, Kiessling R, Boniface J (2013) Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes. J Transl Med 11(290):1–9. doi:10.1186/1479-5876-11-290
Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 8(10):4844–4850. doi:10.1021/pr9004162
Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H (2011) Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol 5(3):281–291. doi:10.1016/j.molonc.2011.02.002
Shingyoji M, Iizasa T, Higashiyama M, Imamura F, Saruki N, Imaizumi A, Yamamoto H, Daimon T, Tochikubo O, Mitsushima T, Yamakado M, Kimura H (2013) The significance and robustness of a plasma free amino acid (PFAA) profilebased multiplex function for detecting lung cancer. BMC Cancer 13:77. doi:10.1186/1471-2407-13-77
Sitter B, Bathen T, Hagen B, Arentz C, Skjeldestad FE, Gribbestad IS (2004) Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. MAGMA 16:174–181. doi:10.1007/s10334-003-0025-5
Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15(2):431–440. doi:10.1158/1078-0432.CCR-08-1059
Stover PJ, MacFarlane AJ (2008) Mouse models to elucidate mechanisms of folate-related cancer pathologies. Nutr Rev 1:54–58. doi:10.1111/j.1753-4887.2008.00069.x
Su L, Li H, Xie A, Liu D, Rao W, Lan L, Li X, Li F, Xiao K, Wang H, Yan P, Li X, Xie L (2015) Dynamic changes in amino acid concentration profiles in patients with sepsis. PLoS One 10(4):e0121933. doi:10.1371/journal.pone.0121933
VanderMeer R, Chambers S, Van Dam A, Cutz JC, Goffin JR, Ellis PM (2015) Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care? Curr Oncol 22(4):272–278. doi:10.3747/co.22.2526
Wu G (2009) Amino acids: metabolism, functions, and nutrition. Amino Acids 37(1):1–17. doi:10.1007/s00726-009-0269-0
Wu G (2013) Functional amino acids in nutrition and health. Amino Acids 45(3):407–411. doi:10.1007/s00726-013-1500-6
Yatabe J, Yatabe MS, Ishibashi K, Nozawa Y, Sanada H (2013) Early detection of colon cancer by amino acid profiling using AminoIndex Technology: a case report. Diagn Pathol 8(203):1–4. doi:10.1186/1746-1596-8-203
Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36(3):237–248. doi:10.1016/j.canep.2012.02.007
Zhao Q, Cao Y, Wang Y, Hu Ch, Hu A, Ruan L, Bo Q, Liu Q, Chen W, Tao F, Ren M, Ge Y, Chen A (2014) Plasma and tissue free amino acid profiles and their concentration correlation in patients with lung cancer. Asia Pac J Clin Nutr 23(3):429–436. doi:10.6133/apjcn.2014.23.3.13
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
This article does not contain any studies with animals and human participants performed by any of the authors.
Additional information
Handling Editor: G. J. Peters.
Rights and permissions
About this article
Cite this article
Simińska, E., Koba, M. Amino acid profiling as a method of discovering biomarkers for early diagnosis of cancer. Amino Acids 48, 1339–1345 (2016). https://doi.org/10.1007/s00726-016-2215-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-016-2215-2